Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.

Most models to predict biochemical recurrence (BCR) of prostate cancer use pretreatment serum prostate-specific antigen (PSA), clinical stage and prostate biopsy Gleason grade. We investigated whether human glandular kallikrein 2 (hK2) and free prostate-specific antigen (fPSA) measured in pretreatme...

書誌詳細
主要な著者:	Steuber, T, Vickers, A, Haese, A, Becker, C, Pettersson, K, Chun, F, Kattan, M, Eastham, J, Scardino, P, Huland, H, Lilja, H
フォーマット:	Journal article
言語:	English
出版事項:	2006

類似資料

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
著者:: Haese, A, 等
出版事項: (2001)

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
著者:: Olsson, A, 等
出版事項: (2005)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
著者:: Steuber, T, 等
出版事項: (2007)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
著者:: Becker, C, 等
出版事項: (2001)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
著者:: Haese, A, 等
出版事項: (2003)

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
著者:: Steuber, T, 等
出版事項: (2005)

Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
著者:: Björk, T, 等
出版事項: (2001)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
著者:: Steuber, T, 等
出版事項: (2007)

Erratum: Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy (International Journal of Cancer (2009) 125 (659-663) DOI:10.1002/ijc.23983)
著者:: Wenske, S, 等
出版事項: (2010)

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
著者:: Lilja, H
出版事項: (2001)

PSA is dead, long live PSA.
著者:: Vickers, A, 等
出版事項: (2012)

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
著者:: Becker, C, 等
出版事項: (2000)

Standardization of two immunoassays for human glandular kallikrein 2.
著者:: Haese, A, 等
出版事項: (2003)

Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.
著者:: Becker, C, 等
出版事項: (2000)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
著者:: Haese, A, 等
出版事項: (2000)

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
著者:: O'Brien, M, 等
出版事項: (2009)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
著者:: Nurmikko, P, 等
出版事項: (2002)

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
著者:: Wenske, S, 等
出版事項: (2009)

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
著者:: Janssen, S, 等
出版事項: (2006)

Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
著者:: Denmeade, SR, 等
出版事項: (2001)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
著者:: Haese, A, 等
出版事項: (2005)

Development of sensitive immunoassays for free and total human glandular kallikrein 2.
著者:: Väisänen, V, 等
出版事項: (2004)

Prostate cancer: estimating the benefits of PSA screening.
著者:: Vickers, A, 等
出版事項: (2009)

Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood.
著者:: Rissanen, M, 等
出版事項: (2007)

Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
著者:: Ulmert, D, 等
出版事項: (2008)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
著者:: Becker, C, 等
出版事項: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
著者:: Becker, C, 等
出版事項: (2003)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
著者:: Sävblom, C, 等
出版事項: (2005)

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.
著者:: Ulmert, D, 等
出版事項: (2012)

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
著者:: Haese, A, 等
出版事項: (2003)

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
著者:: Haese, A, 等
出版事項: (2003)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
著者:: Törnblom, M, 等
出版事項: (2001)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
著者:: Blijenberg, BG, 等
出版事項: (2003)

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor.
著者:: Malm, J, 等
出版事項: (2000)

We need a better marker for prostate cancer. How about renaming PSA?
著者:: Vickers, A, 等
出版事項: (2012)

P5 First screening round results of the ProScreen trial with PSA, kallikrein panel and MRI
著者:: A.S. Rannikko, 等
出版事項: (2024-05-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
著者:: Sävblom, C, 等
出版事項: (2009)

Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
著者:: Ylikoski, A, 等
出版事項: (2001)

Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
著者:: Nurmikko, P, 等
出版事項: (2000)

The evolution of the glandular kallikrein locus: identification of orthologs and pseudogenes in the cotton-top tamarin.
著者:: Olsson, A, 等
出版事項: (2004)